BACKGROUND: Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. METHODS: We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. RESULTS: Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. CONCLUSIONS: Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.
BACKGROUND:Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. METHODS: We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. RESULTS: Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. CONCLUSIONS: Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.
Authors: Maria Labandeira-Rey; Dana A Dodd; Chad A Brautigam; Kate R Fortney; Stanley M Spinola; Eric J Hansen Journal: Infect Immun Date: 2013-08-26 Impact factor: 3.441
Authors: Dharanesh Gangaiah; Wei Li; Kate R Fortney; Diane M Janowicz; Sheila Ellinger; Beth Zwickl; Barry P Katz; Stanley M Spinola Journal: Infect Immun Date: 2012-12-10 Impact factor: 3.441
Authors: Dharanesh Gangaiah; Xinjun Zhang; Beth Baker; Kate R Fortney; Hongyu Gao; Concerta L Holley; Robert S Munson; Yunlong Liu; Stanley M Spinola Journal: Infect Immun Date: 2016-04-22 Impact factor: 3.441
Authors: Dharanesh Gangaiah; Xinjun Zhang; Kate R Fortney; Beth Baker; Yunlong Liu; Robert S Munson; Stanley M Spinola Journal: J Bacteriol Date: 2013-05-31 Impact factor: 3.490
Authors: Michael P Trombley; Deborah M B Post; Sherri D Rinker; Lorri M Reinders; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Fitsum M Baye; Barry P Katz; Stanley M Spinola; Margaret E Bauer Journal: PLoS One Date: 2015-04-22 Impact factor: 3.240
Authors: Julia J van Rensburg; Huaiying Lin; Xiang Gao; Evelyn Toh; Kate R Fortney; Sheila Ellinger; Beth Zwickl; Diane M Janowicz; Barry P Katz; David E Nelson; Qunfeng Dong; Stanley M Spinola Journal: mBio Date: 2015-09-15 Impact factor: 7.867